Cardiopulmonary Manifestations of Ankylosing Spondylitis
Author Information
Author(s): Mahnaz Momeni, Nora Taylor, Mahsa Tehrani
Primary Institution: The George Washington University Medical Center
Conclusion
Ankylosing spondylitis can lead to significant cardiac and pulmonary complications, which may begin before joint symptoms appear.
Supporting Evidence
- Cardiac dysfunction is reported in 2-10% of patients with ankylosing spondylitis.
- Pulmonary manifestations include interstitial lung disease and sleep apnea.
- High-resolution computed tomography has revealed more extensive lung involvement than previously thought.
- Early detection of cardiopulmonary disease may improve patient outcomes.
Takeaway
Ankylosing spondylitis can affect your heart and lungs, even if you don't have joint pain yet.
Methodology
The study reviewed various reports and studies on the cardiac and pulmonary manifestations associated with ankylosing spondylitis.
Potential Biases
Potential bias due to the reliance on existing literature and varying methodologies in the studies reviewed.
Limitations
The study lacks clear guidelines for screening and has limited sample sizes in some referenced studies.
Participant Demographics
Primarily young men with ankylosing spondylitis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website